1. Home
  2. RBKB vs HUMA Comparison

RBKB vs HUMA Comparison

Compare RBKB & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

HOLD

Current Price

$17.07

Market Cap

185.5M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.67

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
HUMA
Founded
1860
2004
Country
United States
United States
Employees
N/A
184
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.5M
191.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
RBKB
HUMA
Price
$17.07
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$6.19
AVG Volume (30 Days)
45.2K
18.0M
Earning Date
04-23-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
215.00
N/A
EPS
0.20
N/A
Revenue
$2,984,000.00
N/A
Revenue This Year
N/A
$444.16
Revenue Next Year
N/A
$248.39
P/E Ratio
$85.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$0.55
52 Week High
$17.99
$2.84

Technical Indicators

Market Signals
Indicator
RBKB
HUMA
Relative Strength Index (RSI) 55.08 36.22
Support Level $15.10 $0.65
Resistance Level $17.92 $1.26
Average True Range (ATR) 0.20 0.07
MACD -0.07 0.00
Stochastic Oscillator 45.45 10.91

Price Performance

Historical Comparison
RBKB
HUMA

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: